Le Bonheur Children's Hospital
Memphis, Tennessee, 38103, United States
Location status: Recruiting
Location contact
Katie Williams
CONTACT
Mark Weems, MD
CONTACT
Mark Weems, MD
CONTACT
NCT Number: NCT06821776
Hospitalized infants with severe bronchopulmonary dysplasia (BPD) and feeding intolerance will be randomized to 2 weeks of continuous gastric feeding or continuous transpyoloric feeding. Subjects will crossover after 2 weeks and receive 4 weeks of each feeding mode. Respiratory status will be assessed to determine the optimal feeding mode for each infant.
Interested in participating?
Request Info1 month–1 year
All sexes
Interventional
Not applicable
Memphis, Tennessee, 38103, United States
Location status: Recruiting
Katie Williams
CONTACT
Mark Weems, MD
CONTACT
Mark Weems, MD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be fed through a feeding tube that empties into the stomach.
Subjects will be fed through a feeding tube that passes through the stomach and empties directly into the small intestine.
Time frame: 8 weeks
RSS (the product of mean airway pressure and oxygen fraction) will be calculated before and after each 2-week intervention block.
Le Bonheur Children's Hospital
Other
N-of-1 Trial Comparing Prolonged Gastric Feeding to Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06475976
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07633184
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Modena, Italy
View Trial DetailsNCT07561125
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Shanghai, China
View Trial DetailsNCT06534359
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Palo Alto, California, United States
View Trial Details